In Bonnie Steinbock (ed.), The Oxford Handbook of Bioethics. Oxford University Press (2009)

Authors
Allen Buchanan
University of Arizona
Abstract
While acknowledging the potential benefits of pharmacogenomics as a methodology, a number of comprehensive reports in the past several years examine a multitude of ethical, legal, and social factors that may limit the extent to which these benefits are realized — and realized in ethically acceptable ways. This article aims to identify and explore the most basic ethical and regulatory issues that are likely to arise if pharmacogenomics becomes widely enough used to have a significant impact on research and clinical practice. First, however, it addresses the question of whether pharmacogenomic tests are unique when compared to other genetic tests and thus deserving of more or less stringent ethical and regulatory requirements.
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1093/oxfordhb/9780199562411.003.0024
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 54,410
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

No references found.

Add more references

Citations of this work BETA

Add more citations

Similar books and articles

Pharmacogenomics, Ethics, and Public Policy.Karen Peterson-Iyer - 2008 - Kennedy Institute of Ethics Journal 18 (1):pp. 35-56.
Ontological Issues in Pharmacogenomics.Russ B. Altman - 2007 - The Monist 90 (4):523-533.
Pharmacogenomics: Social, Ethical, and Clinical Dimensions.A. Hedgecoe - 2004 - Journal of Medical Ethics 30 (6):e6-e6.
Innovative Surgery: The Ethical Challenges.Jane Johnson & Wendy Rogers - 2012 - Journal of Medical Ethics 38 (1):9-12.
The Troubling Persistence of Race in Pharmacogenomics.Jonathan Kahn - 2012 - Journal of Law, Medicine and Ethics 40 (4):873-885.

Analytics

Added to PP index
2014-04-03

Total views
20 ( #502,000 of 2,367,995 )

Recent downloads (6 months)
1 ( #556,092 of 2,367,995 )

How can I increase my downloads?

Downloads

My notes